0.62Open0.65Pre Close1 Volume949 Open Interest1.00Strike Price62.00Turnover184.83%IV5.24%PremiumAug 16, 2024Expiry Date0.60Intrinsic Value100Multiplier24DDays to Expiry0.02Extrinsic Value100Contract SizeAmericanOptions Type-0.9618Delta0.6055Gamma0.67Leverage Ratio-0.0003Theta-0.0002Rho-0.64Eff Leverage0.0001Vega
Sangamo Therapeutics Stock Discussion
Sangamo Therapeutics recently presented critical pre-clinical data on its innovative next-generation integrase technology, the Modular Integrase (MINT) platform, highlighting a significant advancement in the field of genome editing. The announcement came as part of their participation at the 27th Amer...
No comment yet